Bliss GVS Pharma Limited (BLISSGVS.NS)
INR 169.0
(0.87%)
INR 169.0
(0.87%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 7.7 Billion | 7.51 Billion | 7.37 Billion | 5.68 Billion | 6.81 Billion | 8.86 Billion |
| Cost of Revenue | 4 Billion | 4.01 Billion | 3.9 Billion | 3.28 Billion | 4.39 Billion | 6.12 Billion |
| Gross Profit | 3.69 Billion | 3.5 Billion | 3.46 Billion | 2.39 Billion | 2.41 Billion | 2.73 Billion |
| Operating Expenses | 1.41 Billion | 2.51 Billion | 2.28 Billion | 1.48 Billion | 1.28 Billion | 1.14 Billion |
| Selling, General and Administrative Expenses | 1.41 Billion | 494.41 Million | 540.52 Million | 279.2 Million | 271.8 Million | 276.87 Million |
| Research and Development Expenses | 152.29 Million | 217.88 Million | 213.79 Million | 104 Million | 76.88 Million | 142.57 Million |
| Other Expenses | 287.37 Million | 177.86 Million | 25.48 Million | 27.41 Million | 14.62 Million | 5.71 Million |
| Cost and Expenses | 6.42 Billion | 6.52 Billion | 6.19 Billion | 4.77 Billion | 5.68 Billion | 7.26 Billion |
| Operating Income | 1.23 Billion | 986.49 Million | 1.01 Billion | 894.47 Million | 1.11 Billion | 1.51 Billion |
| Interest Expense | 69.12 Million | 103.64 Million | 29.29 Million | 43 Million | 48.3 Million | 41.39 Million |
| Income Tax Expense | 352.94 Million | 291.54 Million | 310.38 Million | 301.55 Million | 337.12 Million | 552.5 Million |
| Earnings before Tax | 1.16 Billion | 1.06 Billion | 541.65 Million | 1.04 Billion | 1.28 Billion | 1.81 Billion |
| Net Income | 754.54 Million | 708.58 Million | 150.4 Million | 684.9 Million | 972.65 Million | 1.23 Billion |
| Earnings Per Share Basic | 7.23 | 6.83 | 1.46 | 6.64 | 9.43 | 11.99 |
| Earnings Per Share Diluted | 7.11 | 6.72 | 1.43 | 6.49 | 9.43 | 11.99 |
| Weighted Average Shares Outstanding | 104.36 Million | 103.8 Million | 103.33 Million | 103.14 Million | 103.14 Million | 103.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 106.07 Million | 105.47 Million | 105.2 Million | 105.47 Million | 103.14 Million | 103.14 Million |
| Gross Margin | 0.48 | 0.47 | 0.47 | 0.42 | 0.35 | 0.31 |
| EBIT Margin | 0.19 | 0.18 | 0.22 | 0.22 | 0.24 | 0.23 |
| Profit Margin | 0.10 | 0.09 | 0.02 | 0.12 | 0.14 | 0.14 |
| EBITDA | 1.47 Billion | 1.35 Billion | 762.36 Million | 1.26 Billion | 1.49 Billion | 1.95 Billion |
| Earnings Before Tax Margin | 0.16 | 0.13 | 0.14 | 0.16 | 0.16 | 0.17 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.17 Billion | 1.83 Billion | 1.98 Billion | 7.7 Billion | 2 Billion | 2.11 Billion |
| Cost of Revenue | 1.14 Billion | 1.18 Billion | 1.26 Billion | 5.04 Billion | 1.02 Billion | 997.35 Million |
| Gross Profit | 1.02 Billion | 651.15 Million | 713.01 Million | 2.66 Billion | 982.31 Million | 1.12 Billion |
| Operating Expenses | 682.58 Million | 376.33 Million | 498 Million | 1.41 Billion | 614.91 Million | 641.64 Million |
| Selling, General and Administrative Expenses | 337.7 Million | 376.33 Million | 498 Million | - | 302.49 Million | 345.11 Million |
| Research and Development Expenses | - | - | 152.29 Million | - | - | - |
| Other Expenses | 682.58 Million | 41.22 Million | 55.99 Million | 287.37 Million | 54.22 Million | 126.01 Million |
| Cost and Expenses | 1.83 Billion | 1.56 Billion | 1.76 Billion | 6.46 Billion | 1.63 Billion | 1.63 Billion |
| Operating Income | 344.95 Million | 274.81 Million | 215.01 Million | 1.24 Billion | 421.62 Million | 605.78 Million |
| Interest Expense | 38.26 Million | 15.31 Million | 18.53 Million | 69.12 Million | 21.17 Million | 14.49 Million |
| Income Tax Expense | 100.13 Million | 79.66 Million | 9.64 Million | 352.94 Million | 109.72 Million | 160.85 Million |
| Earnings before Tax | 357.06 Million | 300.73 Million | -39.48 Million | 1.16 Billion | 400.44 Million | 591.29 Million |
| Net Income | 242.6 Million | 206.97 Million | -91.47 Million | 754.54 Million | 276.1 Million | 423.06 Million |
| Earnings Per Share Basic | 2.31 | 1.97 | -0.88 | - | 2.64 | 4.05 |
| Earnings Per Share Diluted | 2.29 | 1.93 | -0.86 | - | 2.60 | 3.98 |
| Weighted Average Shares Outstanding | 105.02 Million | 104.88 Million | 103.95 Million | 104.36 Million | 104.58 Million | 104.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 105.94 Million | 107.24 Million | 106.36 Million | 106.12 Million | 106.19 Million | 106.29 Million |
| Gross Margin | 0.47 | 0.35 | 0.36 | 0.35 | 0.49 | 0.53 |
| EBIT Margin | 0.21 | 0.19 | 0.14 | - | 0.24 | 0.32 |
| Profit Margin | 0.11 | 0.11 | -0.05 | 0.10 | 0.14 | 0.20 |
| EBITDA | 465.14 Million | 343.3 Million | 283.47 Million | - | 491.16 Million | 669.7 Million |
| Earnings Before Tax Margin | 0.16 | 0.15 | 0.11 | 0.16 | 0.21 | 0.29 |
SPX
0QOB
RSWM
MDEVF
GXUSF
CWK